Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder

European Journal of Clinical Pharmacology

Volumn 67, Issue 12, 2011, Pages 1213-1221

  Ishiguro, Shin ^a   Watanabe, Takashi ^a   Ueda, Mikito ^a   Saeki, Yoshinori ^a   Hayashi, Yuki ^a   Akiyama, Kazufumi ^a   Saito, Atsushi ^a   Kato, Kazuko ^b   Inoue, Yoshimasa ^c   Shimoda, Kazutaka ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b Sakura la Mental Clinic   (Japan)

^c Mitsubishi Tanabe Pharma Factory Ltd   (Japan)

Author keywords

Genetic polymorphism; Panic disorder; Paroxetine; Serotonin 1A receptor; Serotonin transporter

Indexed keywords

PAROXETINE;

ABNORMAL SENSATION; ADULT; AGED; AGITATION; AKATHISIA; ANOREXIA; ANXIETY; ARTICLE; BEDTIME DOSAGE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DISEASE SEVERITY; DNA POLYMORPHISM; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PANIC; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOLOGIC ASSESSMENT; SEROTONIN 1A RECEPTOR GENE; SIDE EFFECT; TREATMENT RESPONSE; VERTIGO; XEROSTOMIA;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PAROXETINE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 82455167894     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1073-9     Document Type: Article

References (31)

1. RC Kessler WT Chiu R Jin AM Ruscio K Shear EE Walters 2006 The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication Arch Gen Psychiatry 63 415 424 16585471 10.1001/archpsyc.63.4.415
2. P Carlbring H Gustafsson L Ekselius G Andersson 2002 12-month prevalence of panic disorder with or without agoraphobia in the Swedish general population Soc Psychiatry Psychiatr Epidemiol 37 207 211 12107711 10.1007/s00127-002-0542-y (Pubitemid 36067953)
3. RR Crowe R Noyes DL Pauls D Slymen 1983 A family study of panic disorder Arch Gen Psychiatry 40 1065 1069 6625855 1:STN:280:DyaL2c%2FitlShtQ%3D%3D (Pubitemid 13006219)
4. EL Harris R Noyes Jr RR Crowe DR Chaudhry 1983 Family study of agoraphobia. Report of a pilot study Arch Gen Psychiatry 40 1061 1064 6625854 1:STN:280:DyaL2c%2FitlShtA%3D%3D (Pubitemid 13006218)
5. I Skre S Onstad S Torgersen S Lygren E Kringlen 1993 A twin study of DSM-III-R anxiety disorders Acta Psychiatr Scand 88 85 92 8213211 10.1111/j.1600-0447.1993.tb03419.x 1:STN:280:DyaK2c%2Fis1emsw%3D%3D (Pubitemid 23225827)
6. JM Hettema MC Neale KS Kendler 2001 A review and meta-analysis of the genetic epidemiology of anxiety disorders Am J Psychiatry 158 1568 1578 11578982 10.1176/appi.ajp.158.10.1568 1:STN:280:DC%2BD3MrjtF2hsA%3D%3D (Pubitemid 32923644)
7. A Heils A Teufel S Petri G Stober P Riederer D Bengel KP Lesch 1996 Allelic variation of human serotonin transporter gene expression J Neurochem 66 2621 2624 8632190 10.1046/j.1471-4159.1996.66062621.x 1:CAS:528: DyaK28XjtFCrsrk%3D (Pubitemid 26159101)
8. J Deckert M Catalano A Heils D Di Bella F Friess E Politi P Franke MM Nothen W Maier L Bellodi KP Lesch 1997 Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder Psychiatr Genet 7 45 47 9264139 10.1097/00041444-199700710-00008 1:STN:280: DyaK2svgvFOqsQ%3D%3D (Pubitemid 27356821)
9. SP Hamilton GA Heiman F Haghighi S Mick DF Klein SE Hodge MM Weissman AJ Fyer JA Knowles 1999 Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder Psychiatr Genet 9 1 6 10335545 10.1097/00041444-199903000-00001 1:STN:280:DyaK1M3mvVShtA%3D%3D
10. H Ishiguro T Arinami K Yamada Y Otsuka M Toru H Shibuya 1997 An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population Psychiatry Clin Neurosci 51 333 335 9413883 10.1111/j.1440-1819.1997.tb03208.x 1:STN:280:DyaK1c%2FnsFyjtg%3D%3D (Pubitemid 27463158)
11. OF Olesen B Bennike ES Hansen P Koefoed DP Woldbye TG Bolwig E Mellerup 2005 The short/long polymorphism in the serotonin transporter gene promoter is not associated with panic disorder in a Scandinavian sample Psychiatr Genet 15 159 16094247 10.1097/00041444-200509000-00003 (Pubitemid 41231935)
12. C Blaya GA Salum MS Lima S Leistner-Segal GG Manfro 2007 Lack of association between the Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and Panic Disorder: a systematic review and meta-analysis Behav Brain Funct 3 41 10.1186/1744-9081-3-41 17705872 10.1186/1744-9081-3-41 (Pubitemid 47505539)
13. G Perna E Favaron D Di Bella R Bussi L Bellodi 2005 Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene Neuropsychopharmacology 30 2230 2235 16034444 10.1038/sj.npp.1300822 1:CAS:528:DC%2BD2MXht1WqurvO (Pubitemid 41643974)
14. B Le Francois M Czesak D Steubl PR Albert 2008 Transcriptional regulation at a HTR1A polymorphism associated with mental illness Neuropharmacology 55 977 985 18639564 10.1016/j.neuropharm.2008.06.046
15. C Rothe L Gutknecht C Freitag R Tauber R Mossner P Franke J Fritze G Wagner G Peikert B Wenda P Sand C Jacob M Rietschel MM Nothen H Garritsen R Fimmers J Deckert KP Lesch 2004 Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia Int J Neuropsychopharmacol 7 189 192 14984628 10.1017/S1461145703004061 1:CAS:528:DC%2BD2cXjs12mtbY%3D (Pubitemid 38823287)
16. B Bandelow 1995 Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The panic and agoraphobia scale Int Clin Psychopharmacol 10 73 81 7673659 10.1097/00004850-199506000-00003 1:STN:280:DyaK2Mvgtl2itA%3D%3D
17. K Hikida Y Inoue E Nouchi Y Ohkura 1990 Determination of etizolam in human serum or plasma using automated column-switching high-performance liquid chromatography Jpn J Clin Chem 19 354 359 1:CAS:528:DyaK3MXhtFCmsLg%3D
18. T Watanabe M Ueda Y Saeki G Hirokane S Morita M Okawa K Akiyama K Shimoda 2007 High plasma concentrations of paroxetine impede clinical response in patients with panic disorder Ther Drug Monit 29 40 44 17304148 10.1097/FTD.0b013e31802bb194 1:CAS:528:DC%2BD2sXhslCmtb8%3D (Pubitemid 46279874)
19. Y Saeki T Watanabe M Ueda A Saito K Akiyama Y Inoue G Hirokane S Morita N Yamada K Shimoda 2009 Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder Eur J Clin Pharmacol 65 685 691 19259652 10.1007/s00228-009-0633-8 1:CAS:528:DC%2BD1MXmvFGhsb8%3D
20. KP Lesch D Bengel A Heils SZ Sabol BD Greenberg S Petri J Benjamin CR Muller DH Hamer DL Murphy 1996 Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 274 1527 1531 8929413 10.1126/science.274.5292.1527 1:CAS:528:DyaK28Xnt1ansL8%3D (Pubitemid 26403928)
21. Stahl SM (2000) Essential psychopharmacology, 2nd edn. Cambridge University Press, New York
22. AK Louie TB Lewis RA Lannon 1993 Use of low-dose fluoxetine in major depression and panic disorder J Clin Psychiatry 54 435 438 8270588 1:STN:280:DyaK2c%2FpsFKjug%3D%3D (Pubitemid 24020599)
23. HG Ruhé J Booij HCV Weert JB Reitsma EJF Fransen MC Michel AH Schene 2009 Evidence why paroxetine dose escalation is not effective in major depressive disorder: a randomized controlled trial with assessment of serotonin transporter occupancy Neuropsychopharmacology 34 999 1010 18830236 10.1038/npp.2008.148
24. 11C]DASB PET imaging study Am J Psychiatry 158 1843 1849 11691690 10.1176/appi.ajp.158.11.1843 1:STN:280:DC%2BD3MnksFGrtA%3D%3D (Pubitemid 33054777)
25. SM Stahl 2002 Independent actions on fear circuits may lead to therapeutic synergy for anxiety when combining serotonergic and GABAergic agents J Clin Psychiatry 63 854 855 12416593 10.4088/JCP.v63n1001 (Pubitemid 35231724)
26. SP David NV Murthy EA Rabiner MR Munafo EC Johnstone R Jacob RT Walton PM Grasby 2005 A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans J Neurosci 25 2586 2590 15758168 10.1523/JNEUROSCI.3769-04.2005 1:CAS:528:DC%2BD2MXis1ygs7g%3D (Pubitemid 40365170)
27. S Lemonde G Turecki D Bakish L Du PD Hrdina CD Bown A Sequeira N Kushwaha SJ Morris A Basak XM Ou PR Albert 2003 Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide J Neurosci 23 8788 8799 14507979 1:CAS:528: DC%2BD3sXnvVWlsr8%3D (Pubitemid 37176660)
28. PR Albert S Lemonde 2004 5HT1A receptors, gene repression, and depression: guilt by association Neuroscientist 10 575 593 15534042 10.1177/1073858404267382 1:CAS:528:DC%2BD2cXhtFagt77P (Pubitemid 39546399)
29. RV Parsey DM Olvet MA Oquendo YY Huang RT Ogden JJ Mann 2006 Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study Neuropsychopharmacology 31 1745 1749 16395308 10.1038/sj.npp.1300992 1:CAS:528:DC%2BD28XmvFCntbc%3D (Pubitemid 44106705)
30. OO Yevtushenko MM Oros GP Reynolds 2010 Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism J Affect Disord 123 308 311 19800133 10.1016/j.jad.2009.09.007 1:CAS:528:DC%2BC3cXlt1Sis7w%3D
31. M Czesak S Lemonde EA Peterson A Rogaeva PR Albert 2006 Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism J Neurosci 26 1864 1871 16467535 10.1523/JNEUROSCI.2643-05.2006 1:CAS:528:DC%2BD28XhslCht7g%3D (Pubitemid 43236999)